Description
The gene is composed of 2 exons and one intron and can be found on chromosome 14 at location 60,182,506 -60,185,933. 
Transcription
The transcript length is 1,376 base pairs and the start of the transcript is located in Contig AL049874.3.1.193047. The transcript can be detected in a variety of tissues during mouse development (see below for protein expression) and this has also been confirmed at the protein level (using reporter genes). The transcript is further detected throughout normal mouse mammary gland development with levels being the highest in the embryonic mammary gland and decreasing as the mammary gland differentiates in pregnancy and lactation. In the adult human, it is detected in skeletal muscle, pituitary gland, salivary gland, kidney, lung, and trachea.
Pseudogene
No.
Protein
View of the Six1 protein (total length 284 amino acids) that contains an N-terminal 115 amino acid Six domain (SD), and a 60 amino acid six-type homeodomain (HD). The SD is important for the interaction of Six1 with cofactors and also contributes to DNA binding along with the homeodomain.
Description
Six1 belongs to the Six family of homeoproteins. Amino acids: 284. Predicted Molecular Weight: 32210 Dalton. It exists as a phosphoprotein and is hyperphosphorylated in mitosis.
Expression
During mouse development, Six1 is expressed in otic vesicles, nasal placodes, branchial arches, Rathke¹s pouch, dorsal root ganglion, proximal cranial ganglia, somites, cranial mesenchyme, nephrogenic cords, and limb mesenchyme. Six1 expression in muscles is present throughout myogenesis and into adulthood. 
Function
Six1 is a transcription factor that is known to play a role in the proliferation and survival of precursor cells during normal development in numerous tissues including, amongst others, the kidney, inner ear, and muscle. It is also demonstrated to play a role in the proliferation of cancer cells and in cancer metastasis. It is known to activate several target genes, including cyclin A1, c-MYC, GDNF, and SLC12A2.
Mutations

Germinal
Germline mutations of SIX1 are observed in branchiooto-renal sydrome, an autosomal dominant developmental disorder that is characterized by kidney and urinary tract malformations and hearing loss. The three SIX1 mutations identified to date all interfere with the ability of the Six1 protein to interact with its Eya1 cofactor, and two of the identified mutations additionally affect Six1-DNA binding.
Somatic
The SIX1 gene is amplified in about 5% of breast cancers (infiltrating ductal carcinomas).Overexpression of Six1 has been found in breast cancer, in Wilms¹tumors, and in rhabdomyosarcoma.
Implicated in
Six1 is implicated in a number of cancers including breast cancer, rhabdomyosarcomas, and Wilms' tumors. It has also been implicated in branchio-otorenal syndrome. Note: Six1 is overexpressed in approximately 50% of primary breast cancers and 90% of metastatic lesions. Its overexpression in breast cancer has been linked to increased proliferation of breast cancer cells. Six1 is also a critical mediator of metastasis in a mouse rhabdomyosarcoma model. Disease Breast cancer, wilms' tumor, rhabdomyosarcoma, branchio-oto-renal syndrome, Cytogenetics The SIX1 gene is amplified in human breast cancer Oncogenesis SIX1 is overexpressed in several tumor types, including breast cancer, rhabdomyosarcomas, and Wilms' tumors. It has been implicated in both the proliferation and metastasis of tumor cells.
